DarioHealth Corp. (DRIO) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of DarioHealth Corp. and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
DarioHealth Corp. logo
DRIO
DarioHealth Corp.
$44M
$6.07HealthcareDelayed quote: Oct 6, 2026, 11:57 AM EDT
Metagenomi, Inc. Common Stock logo
MGX
Metagenomi, Inc. Common Stock
$40M
$1.07HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

Total return — DRIO vs MGX

growth of $100 · dividends reinvested · last 3y
DRIO -84.5% (-46.3%/yr)MGX -89.9% (-53.4%/yr)DRIO compounded faster over this window
050100Start $10020252026$16$10
DRIO MGX

DRIO vs MGX: by the numbers

  • •DRIO is the larger company ($44M vs $40M market cap).
  • •DRIO is profitable (322.77% net margin) while MGX runs a net loss (-689.20%).

Metrics side by side

Valuation

MetricDRIOMGX
P/E ratio8.79N/A
P/S ratio2.112.96
P/B ratio0.810.36

Profitability

MetricDRIOMGX
Gross margin56.09%74.29%
Operating margin-163.94%-380.85%
Net margin322.77%-689.20%
ROE123.04%-83.03%
ROIC-78.42%-66.03%

Growth (annualized)

MetricDRIOMGX
Revenue CAGR (5Y)10.10%N/A
Total return CAGR (5Y)-52.92%N/A

Frequently asked

Is DRIO or MGX more profitable?
DRIO runs the higher net margin — DRIO at 322.77% versus MGX at -689.20%.

Go deeper

Full DRIO analysisFull MGX analysisInteractive comparison tool

Dig into the metrics

DarioHealth P/E ratioDarioHealth ROEMetagenomi, Inc. Common Stock ROEDarioHealth operating marginMetagenomi, Inc. Common Stock operating marginDarioHealth revenue growthMetagenomi, Inc. Common Stock revenue growthDarioHealth free cash flowMetagenomi, Inc. Common Stock free cash flow

DarioHealth & Metagenomi, Inc. Common Stock appear in these rankings

Highest ROE StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.